Home >> News >> Business >> Coronary Stents Market Is Expected To Reach US$ 11,622.5 Mn By 2026

Coronary Stents Market Is Expected To Reach US$ 11,622.5 Mn By 2026

The purpose of the report is to illustrate the state of the market of Coronary Stents, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/coronary-stents-market

Market Insights

Coronary artery disease develops in patients when the coronary artery which delivers blood, nutrients and oxygen to heart becomes damaged. The cholesterol containing plaques are deposited in the coronary artery over a period of time which results in inflammation. Repeated vascular cell wall inflammation coupled with atherosclerotic plaque deposition causes the formation of neointima hyperplasia at the site of vessel damage. There is eventually narrowing of the coronary artery which builds tremendous pressure on the heart eventually resulting in myocardial infarction or stroke. Coronary stents are employed for widening the artery at the site of blockade. In the last 2 decades there has been technological advancement in the manufacturing of stents to counteract complication such as restenosis and stent-in-stent procedure. The only limitation the coronary stents market face is the exorbitant price of drug eluting stents and competition exerted by percutaneous coronary intervention.

Drug eluting stents are currently dominating the coronary stents market on account of key factors such as rising prevalence of coronary artery stenosis, technological advancement in the formulation of biodegradable polymers containing antiproliferative agents to prevent restenosis. Drug eluting stents are completely overshadowing the bare metal stents due to the inherent qualities it possess such as surface smoothness, thinner struts and durable metal alloys. Bioresorbable vascular scaffolds are gaining prominence for the treatment of coronary artery diseases due to key factors such as ability to restore the normal vessel shape and function, eliminate vessel irritation and inflammation and excellent patient compliance.

In the present scenario North America dominates the regional segment for coronary stents market. As per the statistics presented by Center for Disease Control and Prevention (CDC) annually 370,000 U.S. citizens die due to coronary artery disease. The American Africans are at a higher risk for cardiovascular disease on account of their unhealthy lifestyle, tobacco smoking and rise in obesity. In Europe, the market growth is determined by the presence of key players such as Abbott Laboratories, Inc. and Medtronic, Plc. pioneering in manufacturing of coronary stents. Asia Pacific is set to register significant growth during the forecast period owing to the rising prevalence of cardiovascular ailment, rise in per capita income and growth in medical tourism.

The major players engaged in the manufacturing of coronary stents are Amaranth Medical, Inc., Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Inc., B. Braun Melsungen AG, C.R. Bard, Inc., Biotronik SE & Co. KG, Medtronic Plc, Terumo Corporation and Microport Scientific Corporation.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Coronary Stents buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Coronary Stents contains:

Analysis and forecast of Coronary Stents market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Coronary Stents market;

Assessment and forecast of Coronary Stents market development;

Financial and business profiles of the leading companies in the Coronary Stents industry.

Scope

– Up to date working Coronary Stents data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Coronary Stents for the period 2018 to 2026

– Planned Coronary Stents additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Coronary Stents projects by region, key countries, and companies

– Details of major planned Coronary Stents projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/59273

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *